Tiliae flos metabolites and their beneficial influence on human gut microbiota biodiversity ex vivo

• Published in: Journal of ethnopharmacology 2022-08, Vol.294, p.115355-115355, Article 115355
• Main Authors: Kruk, Aleksandra, Granica, Sebastian, Popowski, Dominik, Malinowska, Natalia, Piwowarski, Jakub P.
• Format: Article
• Language: English
• Subjects: Anti-inflammatory; Biodiversity; Gut microbiota; Linden flowers; Metabolism; Tilia sp
• ISSN: 0378-8741; 1872-7573
• DOI: 10.1016/j.jep.2022.115355

The linden flower (Tiliae flos) has been used for centuries to treat and relieve symptoms of the common cold, throat irritation, and upper respiratory tract disturbances. Traditionally, this herb is administered orally, and thus it undergoes intestinal metabolism. Although it is pharmacopeial plant material, there are no reports about its interaction with human gut microbiota. The study aimed to determine the interaction between human gut microbiota and the linden flower extracts, resulting in the biotransformation of the extract's constituents and changes in the microbiota composition. The linden flower metabolites were obtained by incubation of extract with human faecal slurries from 5 healthy donors. The UHPLC-DAD-MSn analysis determined the composition of raw extract and analysis of microbial metabolites. The intestinal microbiota isolation and sequencing were used to determine changes in microbiota composition. The anti-inflammatory activity was tested using the LPS-stimulated human neutrophils model and ELISA test. After incubation of linden flower extract with human gut microbiota, twenty metabolites were detected and characterized, and three among them were identified. The extract changed human gut microbiota composition but did not cause dysbiosis (change in the abundance of forty-three genera). Raw extract and their metabolites exhibit different levels of inhibition of cytokines production by LPS-stimulated neutrophils, but the reduction of TNF-α production was observed. The linden flower extract has a beneficial influence on human gut microbiota because it promotes increasing the abundance of bacteria responsible for SCFAs production. The anti-inflammatory effect might be linked to both microbiota composition changes and direct activity of bioavailable metabolites. Increased abundance of SCFAs producers may inhibit the production of pro-inflammatory cytokines. A low concentration of phenolic compounds in metabolized linden flower extract and responsible for anti-inflammatory properties, and the multitude of biological and chemical particles and their interactions may weaken these properties. [Display omitted] •Gut microbiota promotes formation of metabolites from linden flower extract.•The composition of gut microbiota is influenced by linden flower extract.•The linden flower extract favors increasing the abundance of SCFAs production.•Compounds present in the mixture influence TNF-α production from neutrophils.